ASND Ascendis Pharma A/S

Watchlist

140.010
-0.390-0.28%

Trading Jan 6 09:30 ET

8.37BMarket Cap-18.21P/E (TTM)

Ascendis Pharma A/S Key Stats

According to the latest financial report of Ascendis Pharma A/S, the latest earnings per share (TTM) for the company is -1.72. Investing in companies with strong earnings per share can potentially provide higher returns.

Currency: EUR

Quarterly

FCF

Interested in knowing about Ascendis Pharma A/S's free cash flow? The latest report shows it as -101.78M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.

Currency: EUR

Quarterly

Current Ratio

If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Ascendis Pharma A/S shows that the company's current ratio is 1.16, indicating healthy liquidity.

Currency: EUR

Quarterly

Quick Ratio

Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Ascendis Pharma A/S, the quick ratio is 0.81, indicating that the company can meet its short-term debt obligations.

Currency: EUR

Quarterly

ROE

Want to learn more about the financial health of Ascendis Pharma A/S? The latest ROE figure is -104.66%, indicating that the company has stable profitability.

Currency: EUR

Quarterly

ROA

Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Ascendis Pharma A/S, the total asset return on investment (ROA) is -10.71%.

Currency: EUR

Quarterly

Gross Margin

Gross margin can provide insight into a company's pricing strategy and cost structure. Check Ascendis Pharma A/S's latest financial report to see how their gross margin is doing - currently at 80.63%.

Currency: EUR

Quarterly

Net Margin

For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Ascendis Pharma A/S, the net profit margin is -171.52%, which is a good sign for its profitability.

Currency: EUR

Quarterly

Trending US Stocks